Allison Claire, Pratt Judith A
Department of Physiology and Pharmacology, Strathclyde Institute for Biomedical Sciences, University of Strathclyde, Glasgow, UK.
Neuropsychopharmacology. 2006 Mar;31(3):602-19. doi: 10.1038/sj.npp.1300800.
Withdrawal from chronic benzodiazepines is associated with increased anxiety and seizure susceptibility. Neuroadaptive changes in neural activity occur in limbo-cortical structures although changes at the level of the GABA(A) receptor do not provide an adequate explanation for these functional changes. We have employed two diazepam treatment regimes known to produce differing effects on withdrawal aversion in the rat and examined whether withdrawal-induced anxiety was accompanied by changes in AMPA receptor characteristics. Rats were given 28 days treatment with diazepam by the intraperitoneal (i.p.) route (5 mg/kg) and the subcutaneous (s.c.) route (15 mg/kg). Withdrawal anxiety in the elevated plus maze was evident in the group withdrawn from chronic s.c. diazepam (relatively more stable plasma levels) but not from the chronic i.p. group (fluctuating daily plasma levels). In the brains of these rats, withdrawal anxiety was accompanied by increased [3H]Ro48 8587 binding in the hippocampus and thalamus, and decreased GluR1 and GluR2 subunit mRNA expression in the amygdala (GluR1 and GluR2) and cortex (GluR1). The pattern of changes was different in the chronic i.p. group where in contrast to the chronic s.c. group, there was reduced [3H]Ro48 8587 binding in the hippocampus and no alterations in GluR1 and GluR2 subunit expression in the amygdala. While both groups showed reduced GluR1 mRNA subunit expression in the cortex overall, only the agranular insular cortex exhibited marked reductions following chronic i.p. diazepam. Striatal GluR2 mRNA expression was increased in the i.p. group but not the s.c. group. Taken together, these data are consistent with differential neuroadaptive processes in AMPA receptor plasticity being important in withdrawal from chronic benzodiazepines. Moreover, these processes may differ both at a regional and receptor function level according to the behavioral manifestations of withdrawal.
长期使用苯二氮䓬类药物后停药与焦虑增加和癫痫易感性增强有关。边缘-皮质结构中会发生神经活动的神经适应性变化,尽管γ-氨基丁酸A(GABA(A))受体水平的变化并不能充分解释这些功能变化。我们采用了两种已知对大鼠戒断厌恶产生不同影响的地西泮治疗方案,并研究了戒断引起的焦虑是否伴随着α-氨基-3-羟基-5-甲基-4-异恶唑丙酸(AMPA)受体特性的变化。大鼠通过腹腔内(i.p.)途径(5毫克/千克)和皮下(s.c.)途径(15毫克/千克)接受28天地西泮治疗。在从慢性皮下注射地西泮(血浆水平相对更稳定)停药的组中,高架十字迷宫中的戒断焦虑明显,但从慢性腹腔注射组(每日血浆水平波动)停药的组中则不明显。在这些大鼠的大脑中,戒断焦虑伴随着海马体和丘脑[3H]Ro48 8587结合增加,杏仁核(GluR1和GluR2)和皮质(GluR1)中GluR1和GluR2亚基信使核糖核酸(mRNA)表达减少。慢性腹腔注射组的变化模式不同,与慢性皮下注射组相比,海马体中[3H]Ro48 8587结合减少,杏仁核中GluR1和GluR2亚基表达无变化。虽然两组总体上皮质中GluR1 mRNA亚基表达均降低,但只有颗粒下岛叶皮质在慢性腹腔注射地西泮后表现出明显降低。纹状体GluR2 mRNA表达在腹腔注射组中增加,但在皮下注射组中未增加。综上所述,这些数据表明AMPA受体可塑性中的差异性神经适应性过程在长期使用苯二氮䓬类药物停药过程中很重要。此外,根据戒断的行为表现,这些过程在区域和受体功能水平上可能都有所不同。